Amarin CORP Plcuk 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NASDAQ
Amarin Corporation plc reported a significant decrease in total revenue for Q2 2026, primarily driven by a substantial drop in licensing and royalty income, alongside a moderate decline in product revenue.
NASDAQ
Amarin Corporation plc announced its first quarter 2026 financial results, reporting a 7% increase in total revenue to $45.1 million, driven by growth in international product sales and licensing revenue.
NASDAQ
Amarin Corporation plc reported a significantly reduced net loss for Q3 2025, driven by increased U.S. product revenue and strategic European partnership, despite overall nine-month revenue decline.
NASDAQ
Amarin Corporation plc reported a significant increase in net loss for the first half of 2025, driven by restructuring costs from a new European licensing agreement with Recordati and continued challenges in the U.S. market due to generic competition.
NASDAQ
Amarin Corporation plc reports a net loss of $15.7 million for Q1 2025, with product revenue declining due to generic competition in the U.S.
NASDAQ
Amarin Corporation's Q3 2024 results show a decrease in revenue due to generic competition in the U.S., offset by growth in European and international markets.
NASDAQ
Amarin Corporation reported a mixed second quarter with decreased product revenue offset by increased licensing revenue and ongoing restructuring efforts.
NASDAQ
Amarin's Q1 2024 results show a significant revenue decrease due to generic competition in the U.S., while the company continues its strategic restructuring and international expansion efforts.